Literature DB >> 1395091

Hodgkin's cells express a novel pattern of adhesion molecules.

P A Ellis1, D N Hart, B M Colls, J C Nimmo, J E MacDonald, H B Angus.   

Abstract

Adhesion molecules play an important role in the functioning of the immune system, particularly with regard to cell-cell interactions and antigen presentation. Several adhesion molecules are expressed on Hodgkin's disease-derived cell lines and these are important in their molecular interactions as antigen presenting cells (APC). There are no data regarding the expression of many of these adhesion molecules on Reed-Sternberg cells and its mononuclear variant (Hodgkin's cells (HC)) present in pathological material. To obtain this information we undertook an immunohistological study on material from 18 cases of Hodgkin's disease using a panel of MoAbs to examine the expression of adhesion molecules on HC. The HC were shown to express the integrin beta 1 subfamily molecules, LFA-1 (CD11a) and p150,95 (CD11c) in high density but lacked CR3 (CD11b). All of the immunoglobulin gene superfamily adhesion molecules studied were present to some degree on HC, with ICAM-2, in particular, showing moderate to strong expression in most cases. The Hermes antigen CD44 was present in high density but leukosialin (CD43), another molecule present on diverse leucocyte types, was, in general, not detected on HC. These new data showing that ICAM-1, ICAM-2 and LFA-3 are, like LFA-1, expressed on HC emphasize the ability of HC to act as APC. The known adhesion molecule phenotype of the recently defined haematopoietic lineage of human dendritic cells (DC) is broadly similar to that of HC, perhaps supporting the hypothesis that some HC represent a malignancy of an APC (DC) lineage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1395091      PMCID: PMC1554528          DOI: 10.1111/j.1365-2249.1992.tb05842.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Expression of T-cell antigens on Reed-Sternberg cells in a subset of patients with nodular sclerosing and mixed cellularity Hodgkin's disease.

Authors:  M E Kadin; L Muramoto; J Said
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

2.  Expression of the human leukocyte adhesion molecule, LAM1. Identity with the TQ1 and Leu-8 differentiation antigens.

Authors:  T F Tedder; A C Penta; H B Levine; A S Freedman
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

3.  CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1.

Authors:  Y Rosenstein; J K Park; W C Hahn; F S Rosen; B E Bierer; S J Burakoff
Journal:  Nature       Date:  1991-11-21       Impact factor: 49.962

4.  Cellular protein profiles of the Hodgkin's disease cell lines L428, KM-H2 and HDLM-2: a comparative study.

Authors:  B D Hock; D N Hart
Journal:  Leuk Res       Date:  1992       Impact factor: 3.156

5.  Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells.

Authors:  C Schmid; L Pan; T Diss; P G Isaacson
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

6.  Adhesion molecules on human tonsil dendritic cells.

Authors:  T C Prickett; J L McKenzie; D N Hart
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

7.  Hodgkin's disease: a clinicopathologic study of 659 cases.

Authors:  T V Colby; R T Hoppe; R A Warnke
Journal:  Cancer       Date:  1982-05-01       Impact factor: 6.860

8.  Immunophenotypes of Reed-Sternberg cells: a study of 19 cases of Hodgkin's disease in plastic-embedded sections.

Authors:  T T Casey; S J Olson; J B Cousar; R D Collins
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

9.  Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1.

Authors:  A R de Fougerolles; S A Stacker; R Schwarting; T A Springer
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

10.  Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes.

Authors:  A R de Fougerolles; T A Springer
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  6 in total

1.  Classical Hodgkin's disease. Clinical impact of the immunophenotype.

Authors:  R von Wasielewski; M Mengel; R Fischer; M L Hansmann; K Hübner; J Franklin; H Tesch; U Paulus; M Werner; V Diehl; A Georgii
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  CD58 mutations are common in Hodgkin lymphoma cell lines and loss of CD58 expression in tumor cells occurs in Hodgkin lymphoma patients who relapse.

Authors:  F R Abdul Razak; A Diepstra; L Visser; A van den Berg
Journal:  Genes Immun       Date:  2016-07-28       Impact factor: 2.676

Review 3.  Immune regulation in Epstein-Barr virus-associated diseases.

Authors:  R Khanna; S R Burrows; D J Moss
Journal:  Microbiol Rev       Date:  1995-09

4.  BCR activated CLL B cells use both CR3 (CD11b/CD18) and CR4 (CD11c/CD18) for adhesion while CR4 has a dominant role in migration towards SDF-1.

Authors:  Zsuzsa Nagy-Baló; Richárd Kiss; Judit Demeter; Csaba Bödör; Zsuzsa Bajtay; Anna Erdei
Journal:  PLoS One       Date:  2021-07-20       Impact factor: 3.240

Review 5.  Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells.

Authors:  Thomas Menter; Alexandar Tzankov
Journal:  Front Oncol       Date:  2018-03-07       Impact factor: 6.244

6.  Activated Human Memory B Lymphocytes Use CR4 (CD11c/CD18) for Adhesion, Migration, and Proliferation.

Authors:  Zsuzsa Nagy-Baló; Richárd Kiss; Alina Menge; Csaba Bödör; Zsuzsa Bajtay; Anna Erdei
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.